Lv1
30 积分 2024-10-22 加入
TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma
2天前
已完结
Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease
2天前
待确认
Idiopathic multicentric Castleman's disease: a systematic literature review
18天前
已完结
Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease
3个月前
已完结
IFN-γ promotes the progression of iMCD by activating inflammatory monocytes
4个月前
已完结
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman disease
4个月前
已完结
Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases
4个月前
已完结
Identifying Castleman disease from non-clonal inflammatory causes of generalized lymphadenopathy
4个月前
已完结
LRG1, a Novel Serum Biomarker for Idiopathic Multicentric Castleman Disease Activity
4个月前
已关闭
LRG1, a Novel Serum Biomarker for Idiopathic Multicentric Castleman Disease Activity
4个月前
已关闭
皖公网安备34019202002308
